Dovitinib lactate
Modify Date: 2024-01-21 17:02:56
Dovitinib lactate structure
|
Common Name | Dovitinib lactate | ||
|---|---|---|---|---|
| CAS Number | 915769-50-5 | Molecular Weight | 500.523 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H29FN6O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Dovitinib lactateDovitinib (TKI258, CHIR258) is a novel multi-target inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively. |
| Name | CHIR-258 |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C24H29FN6O5 |
|---|---|
| Molecular Weight | 500.523 |
| Exact Mass | 500.218353 |
| PSA | 160.80000 |
| LogP | 2.51610 |
| Storage condition | -20℃ |
| Dovitinib lactate |
| 2-Hydroxypropanoic acid - 4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone hydrate (1:1:1) |
| Unii-69vky8p7ea |
| Propanoic acid, 2-hydroxy-, compd. with 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone, hydrate (1:1:1) |
| dovitinib |
| TKI-258 |